XPO1 is responsible for the nuclear export of many tumor suppressor proteins and cell growth regulators and has been validated as an important target for cancer therapy.9 XPO1 overexpression was also associated with poor relapse-free survival in breast cancer patients (Fig. S1e). This evidence concerns the gene XPO1 and cancer.